Metyor VG 2mg/500mg/0.3mg Tablet SR
Marketer
Cardimind Pharmaceuticals
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.3mg)
Overview Metyor VG 2mg/500mg/0.3mg Tablet SR
DiabetaComb 2mg/500mg/0.3mg Extended-Release Tablets are classified as anti-diabetic medications. This combination therapy is indicated for adult patients with type 2 diabetes mellitus to manage blood glucose control. DiabetaComb should be administered with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continued use is crucial, even with controlled blood sugar, as abrupt cessation can lead to elevated glucose levels, potentially causing kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan that includes dietary modifications, regular physical activity, and weight management as advised by your doctor. The most frequent adverse effect is hypoglycemia (low blood sugar). Familiarize yourself with hypoglycemia symptoms (sweating, dizziness, headache, tremors) and appropriate countermeasures. Regular meals and readily available fast-acting glucose sources (e.g., sugary foods, fruit juice) are essential. Alcohol consumption should be limited due to its potential to exacerbate hypoglycemia. Other possible side effects include altered taste perception, nausea, diarrhea, abdominal discomfort, headache, edema, blurred vision, bone fractures, and upper respiratory infections. Weight gain may also occur. DiabetaComb is contraindicated in patients with type 1 diabetes mellitus, diabetic ketoacidosis, or severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before commencing treatment. Pregnant or lactating women should seek medical counsel before use. Regular blood glucose monitoring is necessary, and your doctor may order blood tests to evaluate blood cell counts and liver function.
Primary Ingredients of Metyor VG 2mg/500mg/0.3mg Tablet SR
There is no text provided to rephrase.
Uses of Metyor VG 2mg/500mg/0.3mg Tablet SR
Managing type 2 diabetes
Major Benefits of Metyor VG 2mg/500mg/0.3mg Tablet SR:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the entire tablet without chewing, crushing, or dividing it. Metyor VG 2mg/500mg/0.3mg Extended-Release Tablets should be administered on an empty stomach.
Common Side effects of Metyor VG 2mg/500mg/0.3mg Tablet SR:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Metyor VG 2mg/500mg/0.3mg Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Metyor VG 2mg/500mg/0.3mg Tablet SR whole; do not break, chew, or crush it. Administer on an empty stomach.
How Metyor VG 2mg/500mg/0.3mg Tablet SR works:
The extended-release tablet, Metyor VG, contains 2mg, 500mg, and 0.3mg of three distinct antidiabetic agents.
SAFETY ADVICE
AlcoholUNSAFE
Combining alcohol and Metyor VG 2mg/500mg/0.3mg SR Tablets is not recommended due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
The use of Metyor VG 2mg/500mg/0.3mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential benefits against any risks before prescribing this medication. Seek medical advice before using this drug during pregnancy.
Breast feedingCONSULT YOUR DOCTOR
Prolonged-release Metyor VG tablets (2mg/500mg/0.3mg) are likely unsafe for breastfeeding mothers. Available evidence from human studies indicates potential transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyUNSAFE
Patients with kidney disease should likely avoid Metyor VG 2mg/500mg/0.3mg Tablet SR, as its use may be unsafe. Medical advice is recommended. The use of Metyor VG 2mg/500mg/0.3mg Tablet SR is contraindicated in those with severe kidney impairment.
LiverCAUTION
Individuals with liver impairment should use Metyor VG 2mg/500mg/0.3mg Tablet SR cautiously, potentially requiring dosage modification. Consult a physician for guidance. A low initial dose is typically prescribed for patients with mild to moderate liver disease; however, its use is contraindicated in those with severe hepatic dysfunction.
What if you forget to take Metyor VG 2mg/500mg/0.3mg Tablet SR :
Should you forget a dose of Metyor VG 2mg/500mg/0.3mg Tablet SR, take it immediately if you remember. However, near the time for your next scheduled dose, omit the missed dose and resume your usual regimen. Never take two doses at once.
Facts to Know About Metyor VG 2mg/500mg/0.3mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently